Author name: Muhammad Ammar

"UK Government Pledges: Ban on Plastic Microbeads by 2017"

Plastic microbeads to be banned by 2017, UK government pledges

BBC News : The UK government has announced plans to ban microbeads used in cosmetics and cleaning products by 2017. The small pieces of plastic commonly found in toothpaste, exfoliating body scrubs and other household products and are thought to damage the environment. Environmentalists fear they are building up in oceans and potentially entering the […]

Plastic microbeads to be banned by 2017, UK government pledges Read More »

"Lindsay Lohan's Case Dismissed: GTA Picture Controversy"

Lindsay Lohan’s case against Rockstar Games over GTA picture dismissed

BBC News : A New York state appeals court has dismissed Lindsay Lohan’s case against Rockstar Games. Lohan was suing Rockstar’s parent company, Take-Two Interactive Software Inc, because she believed a character in Grand Theft Auto V looked like her. Character “Lacey Jonas” is an actress and Lindsay’s legal team say it is based on

Lindsay Lohan’s case against Rockstar Games over GTA picture dismissed Read More »

"Samsung Takes Action: Note 7 Flagship Recall Due to Explosive Battery Risks"

Samsung recalls Note 7 flagship over explosive batteries

BBC News : Samsung Electronics is recalling its flagship Galaxy Note 7 smartphone and said that battery problems were behind phones catching fire.   The decision follows reports in the US and South Korea of the phone “exploding” during or after charging. The South Korean company said customers who had already bought the phone would be

Samsung recalls Note 7 flagship over explosive batteries Read More »

"Encouraging Breakthrough: Alzheimer's Drug Study Shows 'Tantalizing' Results"

Alzheimer drug study gives ‘tantalising’ results

By Caroline Parkinson Health editor, BBC News website A drug that destroys the characteristic protein plaques that build up in the brains of patients with Alzheimer’s is showing “tantalising” promise, scientists say. Experts are cautious because the drug, Aducanumab, is still in the early stages of development. But a study in Nature has shown it is

Alzheimer drug study gives ‘tantalising’ results Read More »

Scroll to Top